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Abstract The diversity of some of the culturable
microorganisms associated with marine flora and fauna
collected off Vizhinjam and Mulloor coast of South India
was evaluated and their bioactive production potential
determined. From a total of 24 bacteria, 4 actinomycetes
and 8 fungi isolated from diverse marine sources, five
bacterial species-BLM3, BSP2, BCS1, BCS4 and BMA6
showed inhibitory activity against at least one of the tested
pathogens viz., Klebsiella pneumonia KU1, Pseudomonas
aeruginosa VL3, Salmonella enterica typhimurium MTCC
98, Escherichia coli MTCC 40, Micrococcus luteus MTCC
105, Staphylococcus simulans MTCC 3610, Proteus vul-
garis MTCC 426, Vibrio fluvialis, Vibrio sp. P3a and
Vibrio sp. P3b. The isolated actinomycetes and fungi did
not produce significant inhibition zones against the tested
pathogens; however, the macroalgal isolated actinomycetes
strain AMA1 produced reddish pigment in Starch Casein
medium which remained stable till the stationary phase of
growth. The marine sediment isolate BCS4, identified as
Bacillus sp. showed wide spectrum of activity against the
tested Gram positive bacteria, S. simulans MTCC 3610 and
Gram negative bacteria, Proteus vulgaris with zone of
inhibitions of 25 and 11 mm respectively. Better extraction
of the bioactive compound was obtained with ethyl acetate
when compared with methanol, benzene and hexane and
TLC analysis revealed the presence of an active compound.
The 16SrRNA sequencing confirmed the potent strain
belong to Bacillus sp. and hence designated Bacillus sp.
BCS4.
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Introduction
The increasing antibiotic resistance pose serious concerns
in health sector and necessitates seeking natural alterna-
tives. The marine ecosystem being less explored, have
prospects for finding novel bioactive producing microbes.
Marine microbes represent a distinctive group of organism
owing to their immense genetic (Strobel and Daisy 2003)
and biochemical diversity (Rusch et al. 2007) and are rich
sources of a large variety of bioactive compounds (Debbab
et al. 2010). These originate mainly in sediments but they
are also present in open oceans in association with other
marine organisms (Supriya and Yogesh 2010). Marine
invertebrates and plants, in particular, represent an envi-
ronment rich in microorganisms that produce compounds
with bioactive properties including antibacterial, antifun-
gal, antiviral, anticancer, antifouling and antibiofilm
activities (Glo¨ckner et al. 2012). The microbial symbionts
were been crucial in the discovery of many bioactive
compounds reported earlier. The competition among
microbes for space and nutrients is one of the driving
forces behind the production of precious antibiotics and
other useful pharmaceuticals in the marine environment
(Thakur et al. 2005b). Microorganisms associated with
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marine invertebrates are proved to be valuable candidates
for drug discovery (Jensen and Fenical 2000; Hentschel
et al. 2003; Imada 2004; Thakur et al. 2005a).
The marine microbes include cellular life forms such as
bacteria, fungi and plankton, along with viruses that free
load along with them. The marine bacteria represent one of
the hardly untapped sources of potent therapeutic and novel
drug leads. The emergence of multidrug resistant bacteria
poses a major threat which in turn forces the discovery of
new potent drugs to replace the conventional antibiotics.
The decline in the discovery of newer antibiotics of the
terrestrial origin necessitates exploring new ecological
niches most notably the marine. Marine bacteria showing
antibacterial activities have been isolated from various
biotypes and most frequently isolated strains belong to the
genus Bacillus, Micrococcus, Pseudomonas, Vibrio,
Flavobacterium, and Alteromonas (Jayanth et al. 2001;
Nithya et al. 2011; Eltmany et al. 2014; Marinho et al.
2009; Baranova and Eqorov 1989; Leon et al. 2010).
However, a major constraint in the discovery of novel
drugs from the marine microbes rely up on the fact that
majority of the marine microbes are uncultivable in the
laboratory conditions. Nevertheless, using cultivated
microorganisms is still the only way to get detailed infor-
mation about microbial characteristics and processes, thus
highlighting the need to further focus on culturing
microorganisms and developing better culturing techniques
(Glo¨ckner et al. 2012).
Marine microbes are rich and yet less harnessed source
of structurally diverse secondary metabolites, many of
which possess unique biological activities. The present
study attempts to isolate and screen novel bioactive pro-
ducing microbes from the Vizhinjam and Mullor area of
the South-west coast of India, which are known for their
rich biodiversity and novel compounds in them.
Materials and methods
Collection of samples
The marine samples for the isolation of microorganisms
were collected from the Vizhinjam and Mulloor coast of
Kerala, India. The geographical position of Vizhinjam
coast is Longitude E 76590 and Latitude N 8220.
The samples collected include the Sepia and Crab from
the fish landing centre in Vizhinjam coast and Limpets,
macroalgae and the sediments from the Mulloor coast. The
samples except marine sediments soon after collection
were washed with sterile distilled water to remove the soil
and brought to the laboratory in sterile polythene bags.
Isolation of associated microbes from the marine
samples
The samples viz., crab, sepia and limpets after removing
their outer shell and intestine and the macroalgae were
crushed. The resultant was serially diluted in normal saline
(0.85 % NaCl) and 0.1 ml spread plated in Zobell Marine
Agar (Hi-Media), glucose agar and starch-casein agar to
determine the growth of bacteria, fungi and actinomycetes
respectively. Similarly, the coastal sediments were serially
diluted and plated. The plates were monitored for 48 h by
incubating at 37 C for distinct bacterial colonies. The
plated glucose agar was incubated at 27 ± 2 C for 48 h
and starch-casein agar at 27 ± 2 C for 5–7 days to
examine the growth of marine fungi and actinomycetes
respectively. In all the cases, CFU/ml was recorded and the
morphologically distinct colonies of the bacteria, fungi and
actinomycetes were streak plated in respective agar plates
to get the auxenic microbial isolate. The pure cultures of
the isolates were stored in glycerol stocks at refrigeration
temperatures for further studies.
Screening of antibacterial activity of the isolated
marine microbes
The indicator strains used to determine the antibacterial
activity of the isolated marine bacteria, fungi and actino-
mycetes included both the human pathogenic and fish
pathogenic bacteria and are listed in Table 1. The bacterial
cultures were stored in agar slants at refrigeration tem-
peratures and were activated in fresh nutrient agar medium
as and when required.
The isolated marine bacteria were inoculated on to
10 ml of Zobell Marine Broth and incubated under shaking
conditions at 37 C for 48 h. After the respective incuba-
tion period, 1 ml of sample was withdrawn from the culture
flask and centrifuged at 10,000 rpm for 15 min. The pellet
was discarded and the supernatant so obtained was filtered
using 0.22 lm microfilter (Hi-Media). The resultant cell
free supernatant was examined for antibacterial activity
against the indicator bacterial strains. For determining the
antibacterial activity of the fungal isolates and actino-
mycetes, the strains were inoculated in glucose broth and
starch-casein broth and incubated for 5 and 7 days
respectively under shaking conditions. The indicator strains
were activated in Nutrient Broth (Hi-Media) by incubating
the inoculated broth for 24 h at 37 C. The antibacterial
activity was detected using the well-diffusion method (BSI
1968). The bacterial culture was swabbed on to Mueller–
Hinton agar (Hi-Media) plates. Using a cork borer, wells of
7 mm diameter was made on the agar plates containing the
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lawn of indicator bacterial strain. The cell free supernatant
(50 ll) of the marine microbes was added to each well and
incubated for 24 h at 37 C. The plates were observed for
the zones of inhibition around the well and the zone
diameter (mm) was recorded.
Determination of growth characteristics
of the potent bacterial isolate
Among the microbes screened for bioactive production,
active marine bacterial isolate BCS4 was subjected to
determination of growth characteristics for effective
extraction of the bioactive compound. The bacterial isolate
BCS4 was inoculated in 100 ml Zobell Marine Broth and
growth and bioactivity was determined every 24 h interval
for 120 h. The determination of growth was carried out by
taking the optical density of the inoculated culture broth at
600 nm after every 24 h. The bioactivity was determined
by assaying the cell-free supernatant against the indicator
strains selected by well-diffusion method as described
earlier.
Extraction and chemical screening of bioactive
compound from the potent isolate
The potent isolate was inoculated into 100 ml of Zobell
Marine Broth and incubated at 37 C for 96 h. The culture
was then centrifuged at 10,000 rpm for 15 min and the
supernatant filtered. The resultant filtrate was extracted
separately with solvents viz., methanol, ethyl acetate,
benzene and hexane @ 1 ml/ml culture supernatant of the
marine isolate and dried at room temperature (28 ± 2 C);
in order to determine the best solvent extraction strategy
for this bioactive compound. The well-diffusion assay
method was used to determine the bioactivity of the
extracted compounds. The solvent which extracted the
compound better was used for the further extraction of the
bioactive compound.
Thin layer chromatography (TLC) technique was
employed to screen the bioactive compound. The crude
ethyl acetate extract obtained from Bacillus sp. BCS4 was
partially purified by TLC using silica gel coated chro-
matography plates. In order to determine the best solvent
system for effective separation of crude compound, solvents
such as ethyl acetate, methanol, chloroform and water were
used in the proportions viz., (1) Ethyl acetate:Methanol:-
Water (20:2.7:2; v/v/v), (2) Ethyl acetate:Methanol:Water
(20:2.8:1; v/v/v) and (3) Chloroform:Methanol (9:1; v/v).
An aliquot of crude extract was spotted onto the silica gel
plate and allowed to dry for a few minutes. Afterwards, the
plate was developed with the solvent as mobile phase in the
earlier mentioned proportion in a previously saturated glass
chamber with eluting solvents for 30 min at room temper-
ature. The developed plate was dried under normal air and
the spots were visualized under visible light. Retention
factor (Rf) value of the spot separated on the TLC Plate was
determined by adopting the formula,
Rf value ¼ Movement of solute from the origin
Movement of the solvent from the origin
The TLC plates were observed for distinct bands. The
compound was eluted from the developed plate by scrap-
ping off silica gel and mixed well with ethyl acetate and
centrifuged for 10 min at 10,000 rpm. The supernatant was
subjected to determination of bioactivity using well-diffu-
sion assay against the indicator strain S. simulans
MTCC3610 and observed for inhibition zone after incu-
bation at 37 C for 24 h.
Table 1 Indicator bacterial
strains used for screening the
antibacterial activity of isolated
Marine microorganisms
Sl. no. Bacterial strains Source
1 Klebsiella pneumoniae KU1 Clinical isolate
2 Pseudomonas aeruginosa VL3 Clinical isolate
3 Salmonella enterica typhimurium MTCC 98 MTCCa
4 Escherichia coli MTCC 40 MTCC
5 Micrococcus luteus MTCC 105 MTCC
6 Staphylococcus simulans MTCC 3610 MTCC
7 Proteus vulgaris MTCC 426 MTCC
8 Vibrio fluvalis Fish pathogen
9 Vibrio sp. P3a Marine isolate
10 Vibrio sp. P3b Marine isolate
a Microbial type culture collection
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Molecular characterization of the strain BCS4
The molecular characterization of the active marine bac-
terial isolate which showed maximum inhibitory activity
against the indicator strains tested were subjected to bio-
chemical and molecular characterization studies based on
16S ribosomal RNA sequencing. The total genomic DNA
extraction of the active bacteria cultured in Zobell Marine
Broth was carried out by Phenol/chloroform extraction
method. The 16S rRNA gene of the isolate was amplified
using Universal Eubacterial 16S rRNA gene primers and
sequenced. The resultant 16S rRNA gene sequence from
the potent isolate BCS4 was compared with other bacterial
sequences from the GenBank nucleotide database with
BLAST (Altschul et al. 1990) to analyse pairwise homol-
ogy and phylogenetically analyzed using MEGA 6.01
software.
Results
Isolation of microorganisms from the marine
invertebrates, macroalgae and coastal sediments
The samples from the marine environment (Vizhinjam and
Mulloor Coast) used for the isolation of marine bacteria,
fungi and actinomycetes include the coastal sediments,
marine invertebrates viz., crab, sepia and limpet and the
marine macroalgae. The isolated microorganisms from the
respective agar plates after spread plating and incubation
for 24 h were streaked to get pure cultures of the same. The
bacteria were grown in Zobell Marine Agar medium; the
list and source of the isolated bacterial strains are presented
in Table 1. The total count of bacteria per ml of the sample
viz., coastal sediments, crab, sepia, limpets and the marine
macroalgae was 6.5 9 106, 3.2 9 105, 5.9 9 105, 1.9 9
105 and 2.8 9 104 CFU respectively (Fig. 1).
The actinomycetes isolated from different samples in
starch-casein agar plates after spread plating and incuba-
tion for 7 days were streaked onto fresh starch-casein agar
plates for getting pure culture of the same. The isolated
actinomycetes from different marine sources are given in
Table 2. The macroalgal isolate AMA2 produced a pig-
mented colony upon incubation which yielded a red
coloured pigmentation in the starch casein agar plate as
well in the culture broth up on 7 days incubation. The total
count of actinomycetes per ml of the sample viz., coastal
sediments, crab, sepia, limpets and the marine macroalgae
was 5.5 9 102, 0, 2.9 9 102, 0 and 1.9 9 102 CFU
respectively (Fig. 1).
Screening of antibacterial activity of the isolated
marine microorganisms
Of the 23 bacteria isolated from different marine sources,
only five (22 %) bacterial strains viz, BLM3, BSP2, BCS1,
BCS4 and BMA6 showed inhibitory activity against at
least one of the tested strains when detected by well-dif-
fusion method. The results revealed that the isolate from
Fig. 1 Marine microbes associated with samples collected off south-
west Coast of India
Table 2 The bacterial, fungal and actinomycetes strains isolated
from marine samples
Marine sample Microbes isolated
Bacteria Fungi Actinomycetes




Crab BCB1 FCB1 –
BCB2 FCB2





Limpets BLM1 FLM1 –
BLM2 FLM2
BLM3
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coastal sediments (BCS4) exhibited a broad activity spec-
trum inhibiting both Gram positive (M. luteus and S. sim-
ulans) and Gram negative (Proteus vulgaris and two Vibrio
sp. P3a and P3b) bacteria.
The spectrum of inhibitory activity was narrow for the
four strains (BLM3, BSP2, BCS1 and BMA6) which
inhibited either one of the indicator strains. The coastal
sediment isolates BSP1 and BSP4 exhibited 100 % inhi-
bition against the marine Vibrio sp. P3a with zone of
inhibition of 25 and 31 mm respectively. None of the
marine actinomycetes and fungal isolates showed inhibi-
tory activity against the tested pathogens. Hence, the bac-
terial isolate BCS4 which showed the highest bioactivity
was subjected to further molecular characterization and
elution of antibacterial compound.
The isolated actinomycetes and fungi did not produce
significant inhibition zones against the tested pathogens;
however, the macroalgal isolated actinomycetes strain
AMA1 produced reddish pigment in Starch Casein medium
which remained stable till the stationary phase of growth
(Fig. 2).
Growth characteristics and bioactive compound
production by the bacterial isolate BCS4
The determination of growth of the potent marine isolate
Bacillus sp. BCS4 revealed that the growth initiated after
about 8 h of incubation, entered into the exponential phase
after 24 h. The bacterium showed a steady growth till the
96th h after which it ceased to grow and entered the sta-
tionary phase followed by the decline. The steady rise in
the growth rate indicated that the production of the
metabolites maximized around 48 to 72 h (Fig. 3). The
growth was followed by the production of bioactive
metabolite which maximized at the 72th h of incubation
and remained stable till the 96th h and decreased thereafter.
Solvent extraction of the bioactive compound
Among the solvents tested for better extraction of the
bioactive compound, ethyl acetate extract gave wide zone
of inhibition (Table 3) against the test strains indicating the
superiority of ethyl acetate over other solvents in extracting
the bioactive compound of BCS4 (Fig. 4).
The partial purification and chemical screening of the
bioactive compound from the crude ethyl acetate extract
was carried out using Thin Layer Chromatography. Dis-
tinct band was detected irrespective of the solvent systems,
which is indicative of the presence of a compound in the
crude extract. The Rf value was measured as 0.60, 0.72 and
0.79 cm for the solvent systems 1, 2 and 3 respectively.
The ethyl acetate extracted compound eluted from the
silica gel plate gave a zone of inhibition of 27.2 ± 0.3 mm
against S. simulans MTCC 3610 confirming the bioactive
potential.
Molecular characterization of the active marine
bacterial isolate
The bacterial strain BCS4 which inhibited majority of the
tested pathogens was characterized using 16S rRNA gene
sequencing and the obtained sequence (749 bp) was blasted
using Megablast tool of GenBank (http://www.ncbi.nlm.
nih.gov). The blast results revealed 98 % similarity with
the Bacillus sp. alk3. The phylogenetic tree was con-
structed through Neighbour Joining Method using Mega
6.0 software (Fig. 5). The active marine isolate was char-
acterized as Bacillus sp. and designated Bacillus sp. BCS4.
Fig. 2 Antibacterial activity of
Marine bacterial isolates
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Discussion
The marine ecosystem is less harnessed in terms of
developing alternative drugs to antibiotics. The rich
diversity, along with extreme physical conditions makes
marine environment an ideal source for proving novel drug
leads. The coasts, Vizhinjam and Mulloor along the south-
west coast of India harbour rich and biodiverse flora and
fauna with millions of microorganisms associated with it.
When compared to the terrestrial counterparts, these flora
and fauna and the marine environment, in general possess
novel drugs and other chemically diverse bioactives (De-
long 2007). Though the percentage of culturable microbes
remains too little, these can provide insights into the
characteristics and potency of microbes (Glo¨ckner et al.
2012) thriving in such extreme conditions.
The marine microbial biota is rich and diverse. The study
on the diversity of microbes from coastal sediments and
marine flora and fauna revealed that the percentage of bacteria
isolated from the studied marine sources was comparatively
higher than actinomycetes and fungi.While no actinomycetes
were isolated from limpets and crab, at least two fungal strains
were isolated from them. Similar observation was made by
Tawiah et al. (2012) for the samples collected from Cape
Coast Duakor Sea beach at Gulf of Guinea in which the fre-
quency of bioactive producing bacteria was high compared to
actinomycetes and fungi. The results from that study also
revealed 27 % antibiotic producingmicroorganism out of 119
isolated recovered. These observations coincided with the
observations of the present study which gave 22 % bioactive
producing bacteria. On the contrary, high rate of isolation of
antibiotic producers (70 %) was recorded by O’Brien et al.
(2004) from the Amazon basin.
Fig. 3 Growth characteristics
andbioactive compound
production of Marine bacterial
isolate BCS4
Table 3 Activity based extraction of the bioactive compound from
Bacillus sp. BCS4 using different solvents
Solvents Zone diameter (mm)
S. simulans P. vulgaris
Methanol ? BCS4 17.8 ± 0.3 6.67 ± 0.6
Benzene ? BCS4 13.7 ± 0.6 6.8 ± 0.3
Ethyl acetate ? BCS4 27.0 ± 0.3 11.7 ± 6
Hexane ? BCS4 – –
Methanol alone – –
Benzene alone – –
Ethyl acetate alone – –
Hexane alone – –
Well diameter = 5 mm; ‘–’ indicates absence of inhibition zone
Fig. 4 Zone of antibacterial inhibition of ethyl extract of Bacillus sp.
BCS4 against S. simulans MTCC3610. a Ethyl acetate extract,
b compound eluted from silica gel plate
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The highest number of active isolates was obtained from
the coastal sediments collected from Vizhinjam coast. The
increased number of active isolates in the sediments than
from the marine flora and fauna studied might be attributed
to fact that the area of sample collection being a Fish
Landing area and prone to pollution with fish wastes and
other waste discharges, the microbes there might have
accustomed to thrive by producing defense compounds.
The findings are supported by the observations of Tawiah
et al. (2012). The study also revealed active compound
producing bacteria and the absence of inhibitory potential
by isolated Actinomycetes and Fungi. The absence of the
zone of inhibition by the fungal and actinomycetes strains
against the tested pathogens might be attributed to the
changes in culture conditions or the limitations in the
strains tested etc. Further, the actinomycetes and fungi
require condition optimization for the production of the
bioactive compounds. This would require the standardiza-
tion of the culture conditions or supplementation with
different media components to enrich the medium to enable
the production of such compounds. The study carried out
Kiranmayi et al. (2011) employed 11 different culture
media in order to determine the best production media for
the isolated actinomycetes. The variations noted in the
antibiotic producers among the isolated strains may also be
due to it’s dependence on the isolation and assay proce-
dure, test organisms, type of media used and the sources of
bacterial isolates (Giudice et al. 2007). A salient finding
noted from the present study that the actinomycete strain
AMA1 produced a reddish pigment in Starch-Casein
medium which remained stable till the stationary phase of
growth. Earlier reports evidenced the production of
antitumour (Soliev et al. 2011; Olano et al. 2009),
antibacterial (Pham et al. 2014) and other commercially
important pigments from marine Actinomycetes. Studies
also revealed prognosin like pigment production by Acti-
nomycetes of marine origin (Quadri and Asgar 2012;
Chaudhary et al. 2013). The studies on production and
determination of the nature of the pigment produced by the
strain AMA1 are needed further for characterization and
evaluating it’s applicational potentiality.
The bacterial isolate from coastal sediments (BCS4)
exhibited a broad activity spectrum inhibiting both Gram
positive (Micrococcus luteus and Staphylococcus simulans)
and Gram negative (Proteus vulgaris and two Vibrio sp.
P3a and P3b) bacteria. Similar broad activity spectrum was
observed with marine Pseudoalteromonas species as was
observed by Isnansetyo and Kamei (2003). The activity
spectrum observed with the marine isolate in the study
provides prospects for a future drug or bioactive lead. The
growth pattern of the bacterial isolate revealed that the
active metabolite production maximized at the late loga-
rithmic phase (i.e., at the 72th h of incubation) and
remained stable till the 96th h. Similar to this observation,
Radhakrishna et al. (2011) noted maximum active
metabolite production of sponge isolated Bacillus subtilis
MTCC 10619 at the 72th h, which decreased thereafter.
The isolate with potent activity was phylogenetically
confirmed as Bacillus sp. BCS4. It is evidenced from the
reports of Mondol et al. (2013) that marine Bacillus iso-
lates produce diverse bioactive metabolites with novel
modes of action and has potentials for the development of
effective management strategies to combat human, animal
and phytopathogens in biorational manners. The activity
Fig. 5 Phylogenetic tree drawn
in MEGA 6.0 software using
Neighbour Joining Method
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spectrum noted for Bacillus sp. BCS4 is indicative of their
possible medical and pharmaceutical applications. The
compound was effectively extracted using the ethyl acetate
solvent and the confirmation of the active compound in
TLC provides insights into development of potent drugs
out of this compound. Further work to detect the compound
chemistry and the purification of the compound to homo-
geneity is under progress.
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